Article
Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel
1 Dec 2022
Abstract excerpt
Background: The identification of driver mutations has greatly promoted the precise diagnosis and treatment of non-small cell lung cancer (NSCLC), but there is lack of targeted sequencing panels specifically designed and applied to Chinese NSCLC patients. This study aimed to design and validate of a novel sequencing panel for comprehensive characterization of driver mutations in Chinese NSCLC patients,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
